Antiviral agents against influenza viruses

Sehee Park, Jin Il Kim, Man Seong Park

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)


In annual epidemics and occasional pandemics, influenza viruses cause acute respiratory illnesses in infected humans. Vaccines and antiviral drugs are two main arsenals available for a fight against influenza viruses. However, vaccines often exhibit a limited efficacy in high risk populations, and antiviral drugs are always concerned for mutations, which confer viral resistance. Here we review current advances and knowledge in relation to the usage of antiviral drugs as a prophylactic or therapeutic and the mechanism of resistant variants mainly against the neuraminidase inhibitors. Comprehensive understanding of the resistant mechanism will pave a road for developing new antivirals and/or finding medical or natural alternatives inducing less frequent resistance, and application of combination therapy using two or three different kinds of antivirals can suggest a useful medical intervention against both of seasonal and highly pathogenic influenza viruses including resistant variants. In this review, we provide insights of antiviral drugs for the control and prevention of influenza viruses.

Original languageEnglish
Pages (from-to)284-293
Number of pages10
JournalJournal of Bacteriology and Virology
Issue number4
Publication statusPublished - 2012


  • Antiviral drugs
  • Combination therapy
  • Influenza
  • Neuraminidase
  • Resistance

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Virology


Dive into the research topics of 'Antiviral agents against influenza viruses'. Together they form a unique fingerprint.

Cite this